AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Clinical trials for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE explained in plain language.
Never miss a new study
Get alerted when new AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE trials appear
Sign up with your email to follow new studies for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for calming Alzheimer's agitation: new drug shows promise in Long-Term trial
Symptom relief CompletedThis study tested a drug called AXS-05 to see if it is safe and effective for treating agitation in people with Alzheimer's disease over a long period. 456 participants who had already been in earlier studies took the drug, and some later switched to a placebo to see if symptoms …
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC
-
Hope for Alzheimer's agitation: new drug shows promise in major trial
Symptom relief CompletedThis study tested an experimental drug called AXS-05 to see if it can safely reduce agitation in people with Alzheimer's disease. Agitation includes restlessness, aggression, and emotional distress. The trial involved 408 participants and compared the drug to a placebo (a dummy p…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 04, 2026 16:17 UTC